Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00141193
Status:
COMPLETED
Last Update Posted:
2008-08-06
First Post:
2005-08-30
Brief Title:
Prevention of Colorectal Sporadic Adenomatous Polyps PRESAP
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Clinical Protocol For a Randomized Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Celecoxib SC-58635 In The Prevention of Colorectal Sporadic Adenomatous Polyps PRESAP
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRESAP
Brief Summary:
This study is a prospective randomized double-blind placebo-controlled multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas post-polypectomy at Month 13 Year 1 and Month 37 Year 3 of study drug administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A3191107 | None | None | None |